Aevum Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Aevum Therapeutics General Information

Description

Developer of a therapeutic drug intended to treat neurodegenerative disorders. The company offers therapeutic molecules derived from exercised muscle to treat diseases such as alzheimer's, parkinson's, and amyotrophic lateral sclerosis, enabling patients to slow cognitive decline and reduce the risk of dementia and other health benefits.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 5554 Coral Drive
  • Unit 105
  • Hawthorne, CA 90250-6182
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 5554 Coral Drive
  • Unit 105
  • Hawthorne, CA 90250-6182
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aevum Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 21-Nov-2023 Completed Out of Business
2. Seed Round Completed Startup
1. Accelerator/Incubator 01-Jan-2021 Completed Startup
To view Aevum Therapeutics’s complete valuation and funding history, request access »

Aevum Therapeutics Patents

Aevum Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026193144-A1 Peptide therapeutics and uses thereof Pending 12-Mar-2025

Aevum Therapeutics FAQs

  • When was Aevum Therapeutics founded?

    Aevum Therapeutics was founded in 2020.

  • Where is Aevum Therapeutics headquartered?

    Aevum Therapeutics is headquartered in Hawthorne, CA.

  • What industry is Aevum Therapeutics in?

    Aevum Therapeutics’s primary industry is Drug Discovery.

  • Is Aevum Therapeutics a private or public company?

    Aevum Therapeutics is a Private company.

  • What is Aevum Therapeutics’s current revenue?

    The current revenue for Aevum Therapeutics is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process